跳至主要内容
临床试验/CTRI/2022/12/047805
CTRI/2022/12/047805尚未招募未知

Therapeutic evaluation of Seer (Allium sativum) in Atherosclerosis in patients of Type 2 Diabetes Mellitus An open randomized controlled trial

Department of Moalejat Faculty of Unani Medicine AKTC Aligarh Muslim University0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients in age group of 30-65 years.
  • Patients of either sex.
  • Controlled case of Type 2 Diabetes Mellitus either by drug or life style modification.
  • Fasting blood sugar <= 140 mg/dl or HbA1c- <= 7%
  • Patients able to participate in the study to follow the instructions
  • Subjective Parameters:
  • Patients showing any one of the following symptoms will be suspected and has to go further screening through Diabetes Risk Profiler and Investigations;
  • 1.Increasing body weight
  • 3.Exertional dyspnea
  • 4.Xanthelasma
  • 5.Corneal arcus
  • 6.Controlled Essential Hypertension
  • Objective Parameters:
  • 1.Arterial stiffness index to be evaluated with Diabetes Risk Profiler (Borderline,
  • Mild & Moderate Arterial stiffness)
  • 2.Fasting blood sugar <= 140 mg/dl or HbA1c- <= 7%
  • 3.Lipid profile:
  • Any two of the following
  • 1.Total Cholesterol: 200-300 mg/dl
  • 2.Serum Triglyceride: 200-300 mg/dl
  • 3.LDL Cholesterol: 100-150 mg/dl
  • 4.HDL Cholesterol: 30-50 mg/dl
  • 5.VLDL Cholesterol: 30-50 mg/dl

排除标准

  • Exclusion Criteria:
  • 1.Patients below 30 years and above 65 years of age.
  • 2.Uncontrolled case of Type 2 Diabetes Mellitus. HbA1c > 7%
  • 3.Arterial Stiffness Index (Severe Arterial Stiffness)
  • 4.Patients on lipid-lowering drugs
  • 5.Any co-morbid condition
  • 6.Alcoholic
  • 7.Pregnant and lactating women.

研究者

发起方
Department of Moalejat Faculty of Unani Medicine AKTC Aligarh Muslim University

相似试验

To assess the therapeutic efficacy of Seer (Allium... | 临床试验